Pharmaceutical Research And Manufacturers Of America Says Suing U.S. Government To Block Enforcement Of Program That Gives Medicare Too Much Power To Set Drug Prices
Portfolio Pulse from Happy Mohamed
Pharmaceutical Research and Manufacturers of America (PhRMA) is suing the U.S. government to block enforcement of a program that gives Medicare too much power to set drug prices.
June 21, 2023 | 2:38 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
PhRMA's lawsuit against the U.S. government may impact Cigna's ability to negotiate drug prices with Medicare.
The lawsuit filed by PhRMA against the U.S. government aims to block a program that gives Medicare more power to set drug prices. If successful, this could impact Cigna's ability to negotiate drug prices with Medicare, but the outcome of the lawsuit is uncertain.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 50
NEUTRAL IMPACT
CVS Health may be affected by PhRMA's lawsuit against the U.S. government over Medicare's power to set drug prices.
PhRMA's lawsuit against the U.S. government could impact CVS Health's ability to negotiate drug prices with Medicare if the program is blocked. However, the outcome of the lawsuit is uncertain, making it difficult to predict the impact on CVS Health.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 50
NEUTRAL IMPACT
UnitedHealth Group may be affected by PhRMA's lawsuit against the U.S. government over Medicare's power to set drug prices.
PhRMA's lawsuit against the U.S. government could impact UnitedHealth Group's ability to negotiate drug prices with Medicare if the program is blocked. However, the outcome of the lawsuit is uncertain, making it difficult to predict the impact on UnitedHealth Group.
CONFIDENCE 80
IMPORTANCE 60
RELEVANCE 50